pilocarpine has been researched along with dicyclomine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gupta, R; Khanna, VK; Konar, A; Lahiri, DK; Maloney, B; Shukla, RK; Thakur, MK; Wadhwa, R | 1 |
1 review(s) available for pilocarpine and dicyclomine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for pilocarpine and dicyclomine
| Article | Year |
|---|---|
M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera.
Topics: Animals; Blotting, Western; Dendrites; Dicyclomine; Female; Male; Memory; Mice; Mice, Transgenic; Nerve Regeneration; Neuroprotective Agents; Pilocarpine; Plant Extracts; Receptor, Muscarinic M1; Reverse Transcriptase Polymerase Chain Reaction; Scopolamine; Withania | 2019 |